As of 3:59pm ET
| +0.14 / +3.33%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 13.75, with a high estimate of 27.00 and a low estimate of 10.00. The median estimate represents a +216.09% increase from the last price of 4.35.
The current consensus among 5 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.